Biological sample collection for clinical proteomics: Existing SOPs

Methods in Molecular Biology

Volumn 1243, Issue , 2015, Pages 3-27

  Lygirou, Vasiliki ^a   Makridakis, Manousos ^a   Vlahou, Antonia ^a  

^a NONE

Author keywords

Biological sample collection; Biomarkers; Body fluids; Clinical proteomics; Protocols

Indexed keywords

CITRATE SODIUM; EDETIC ACID; HEPARIN; LIQUID NITROGEN; LITHIUM; POLYPROPYLENE; PROTEINASE INHIBITOR; SODIUM CHLORIDE;

AMNIOCENTESIS; AMNION FLUID ANALYSIS; ARTERIAL BLOOD; ARTERIAL LINE; ARTICLE; BILE; BLOOD COLLECTION TUBE; BLOOD SAMPLING; BLOOD STORAGE; BODY FLUID; BREAST MILK; CENTRIFUGATION; CEREBROSPINAL FLUID ANALYSIS; CHOLECYSTECTOMY; CLINICAL PROTOCOL; COLOSTRUM; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INTRAVENOUS CATHETER; LACRIMAL FLUID; NASAL LAVAGE; NIPPLE ASPIRATION; NOSE SECRETION; PRIORITY JOURNAL; PROTEOMICS; ROOM TEMPERATURE; SALIVA ANALYSIS; SAMPLING; SECOND TRIMESTER PREGNANCY; SEMINAL PLASMA; SPINAL NEEDLE; STORAGE TEMPERATURE; URINALYSIS; UTERINE CERVIX CYTOLOGY; VEIN PUNCTURE; VENOUS BLOOD; LABORATORY DIAGNOSIS; METABOLISM; PROCEDURES;

BODY FLUIDS; HUMANS; PROTEOMICS; SPECIMEN HANDLING;

EID: 84921709251     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1872-0_1     Document Type: Article

References (89)

1. American Red Cross. Plasma. Available from http://www.redcrossblood.org/learn-aboutblood/blood-components/plasma
2. Omenn GS, Menon R, Adamski M, Blackwell T, Haab BB, Gao W, States DJ (2007) The human plasma and serum proteome. In: Thongboonkerd V (ed) Proteomics of human body fluids. Humana, Totowa
3. Schulte I, Tammen H, Selle H et al (2005) Peptides in body fluids and tissues as markers of disease. Expert Rev Mol Diagn 5:145–157
4. Granger J, Siddiqui J, Copeland S et al (2005) Albumin depletion of human plasma also removes low abundance proteins including the cytokines. Proteomics 5:4713–4718
5. Guerrier L, Righetti PG, Boschetti E (2008) Reduction of dynamic protein concentration range of biological extracts for the discovery of low-abundance proteins by means of hexapeptide ligand library. Nat Protoc 3:883–890
6. Bodzon-Kulakowska A, Bierczynska-Krzysik A, Dylag T et al (2007) Methods for samples preparation in proteomic research. J Chromatogr B Analyt Technol Biomed Life Sci 849:1–31
7. Omenn GS (2007) THE HUPO human plasma proteome project. Proteomics Clin Appl 1:769–779
8. Muthusamy B, Hanumanthu G, Suresh S et al (2005) Plasma Proteome Database as a resource for proteomics research. Proteomics 5:3531–3536
9. Plasma Proteome Database. Available from http://www.plasmaproteomedatabase.org/index.html
10. Rai AJ, Gelfand CA, Haywood BC et al (2005) HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5:3262–3277
11. Kim MR, Kim CW (2007) Human blood plasma preparation for two-dimensional gel electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci 849:203–210
12. Di Domenico M, Scumaci D, Grasso S et al (2013) Biomarker discovery by plasma proteomics in familial Brugada Syndrome. Front Biosci (Landmark Ed) 18:564–571
13. Tammen H (2008) Specimen collection and handling: standardization of blood sample collection. Methods Mol Biol 428:35–42
14. Issaq HJ, Xiao Z, Veenstra TD (2007) Serum and plasma proteomics. Chem Rev 107: 3601–3620
15. Adkins JN, Varnum SM, Auberry KJ et al (2002) Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 1:947–955
16. Putnam DF (1971) Composition and concentrative properties of human urine. National Aeronautics and Space Administration, Washington
17. Rodriguez-Suarez E, Siwy J, Zurbig P et al (2013) Urine as a source for clinical proteome analysis: from discovery to clinical application. Biochim Biophys Acta 1844(5):884–898
18. Mischak H, Kolch W, Aivaliotis M et al (2010) Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin Appl 4: 464–478
19. Yamamoto T (2010) The 4th Human Kidney and Urine Proteome Project (HKUPP) workshop. 26 September 2009, Toronto, Canada. Proteomics 10:2069–2070
20. Yamamoto T, Langham RG, Ronco P et al (2008) Towards standard protocols and guidelines for urine proteomics: a report on the Human Kidney and Urine Proteome Project (HKUPP) symposium and workshop, 6 October 2007, Seoul, Korea and 1 November 2007, San Francisco, CA, USA. Proteomics 8:2156–2159
21. Zurbig P, Dihazi H, Metzger J et al (2011) Urine proteomics in kidney and urogenital diseases: moving towards clinical applications. Proteomics Clin Appl 5:256–268
22. van Gool AJ, Hendrickson RC (2012) The proteomic toolbox for studying cerebrospinal fluid. Expert Rev Proteomics 9:165–179
23. Ramström M, Bergquist J (2007) The human plasma and serum proteome. In: Thongboonkerd V (ed) Proteomics of human body fluids. Humana, Totowa
24. Kroksveen AC, Opsahl JA, Aye TT et al (2011) Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics. J Proteomics 74: 371–388
25. Teunissen CE, Petzold A, Bennett JL et al (2009) A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 73:1914–1922
26. Casado B, Pannell LK, Iadarola P et al (2005) Identification of human nasal mucous proteins using proteomics. Proteomics 5:2949–2959
27. Casado B, Viglio S, Baraniuk JN (2007) Proteomics of sinusitis nasal lavage fluid. In: Thongboonkerd V (ed) Proteomics of human body fluids. Humana, Totowa
28. Casado B, Iadarola P, Pannell L (2008) Preparation of nasal secretions for proteome analysis. In: Posch A (ed) 2D PAGE: sample preparation and fractionation. Humana, Totowa, pp 77–87
29. Caseiro A, Ferreira R, Padrao A et al (2013) Salivary proteome and peptidome profiling in type 1 diabetes mellitus using a quantitative approach. J Proteome Res 12(4): 1700–1709
30. Casado B, Iadarola P, Pannell LK (2008) Preparation of nasal secretions for proteome analysis. Methods Mol Biol 425:77–87
31. Lamy E, Mau M (2012) Saliva proteomics as an emerging, non-invasive tool to study livestock physiology, nutrition and diseases. J Proteomics 75:4251–4258
32. Vitorino R, Guedes S, Manadas B et al (2012) Toward a standardized saliva proteome analysis methodology. J Proteomics 75:5140–5165
33. He H, Sun G, Ping F et al (2011) A new and preliminary three-dimensional perspective: proteomes of optimization between OSCC and OLK. Artif Cells Blood Substit Immobil Biotechnol 39:26–30
34. Goncalves Lda R, Soares MR, Nogueira FC et al (2010) Comparative proteomic analysis of whole saliva from chronic periodontitis patients. J Proteomics 73:1334–1341
35. Rudney JD, Staikov RK, Johnson JD (2009) Potential biomarkers of human salivary function: a modified proteomic approach. Arch Oral Biol 54:91–100
36. Vitorino R, de Morais Guedes S, Ferreira R et al (2006) Two-dimensional electrophoresis study of in vitro pellicle formation and dental caries susceptibility. Eur J Oral Sci 114: 147–153
37. Cabras T, Pisano E, Mastinu A et al (2010) Alterations of the salivary secretory peptidome profile in children affected by type 1 diabetes. Mol Cell Proteomics 9:2099–2108
38. Hu S, Wang J, Meijer J et al (2007) Salivary proteomic and genomic biomarkers for primary Sjogren’s syndrome. Arthritis Rheum 56:3588–3600
39. Ambatipudi KS, Swatkoski S, Moresco JJ et al (2012) Quantitative proteomics of parotid saliva in primary Sjogren’s syndrome. Proteomics 12:3113–3120
40. Wu ZZ, Wang JG, Zhang XL (2009) Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J Gastroenterol 15:865–870
41. Jarai T, Maasz G, Burian A et al (2012) Mass spectrometry-based salivary proteomics for the discovery of head and neck squamous cell carcinoma. Pathol Oncol Res 18:623–628
42. Dowling P, Wormald R, Meleady P et al (2008) Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J Proteomics 71:168–175
43. Xiao H, Zhang L, Zhou H et al (2012) Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics 11(M111):012112
44. WHO (2007) Common minimum technical standards and protocols for biological resource centres dedicated to cancer research. International Agency for Research on Cancer, Working Group Reports. vol. 2
45. Vitorino R, Barros AS, Caseiro A et al (2012) Evaluation of different extraction procedures for salivary peptide analysis. Talanta 94:209–215
46. Ananthi S, Santhosh RS, Nila MV et al (2011) Comparative proteomics of human male and female tears by two-dimensional electrophoresis. Exp Eye Res 92:454–463
47. Saijyothi AV, Angayarkanni N, Syama C et al (2010) Two dimensional electrophoretic analysis of human tears: collection method in dry eye syndrome. Electrophoresis 31:3420–3427
48. Zhou L, Beuerman RW, Chan CM et al (2009) Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res 8:4889–4905
49. Acera A, Rocha G, Vecino E et al (2008) Inflammatory markers in the tears of patients with ocular surface disease. Ophthalmic Res 40:315–321
50. Argueso P, Balaram M, Spurr-Michaud S et al (2002) Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest Ophthalmol Vis Sci 43:1004–1011
51. Saghizadeh M, Brown DJ, Castellon R et al (2001) Overexpression of matrix metalloproteinase- 10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations. Am J Pathol 158:723–734
52. Wong TT, Zhou L, Li J et al (2011) Proteomic profiling of inflammatory signaling molecules in the tears of patients on chronic glaucoma medication. Invest Ophthalmol Vis Sci 52:7385–7391
53. Liao Y, Alvarado R, Phinney B et al (2011) Proteomic characterization of human milk whey proteins during a twelve-month lactation period. J Proteome Res 10:1746–1754
54. Conti A, Giuffrida MG, Cavaletto M (2007) Proteomics of human milk. In: Thongboonkerd V (ed) Proteomics of human body fluids. Humana, Totowa
55. Gao X, McMahon RJ, Woo JG et al (2012) Temporal changes in milk proteomes reveal developing milk functions. J Proteome Res 11:3897–3907
56. Dallas DC, Guerrero A, Khaldi N et al (2013) Extensive in vivo human milk peptidomics reveals specific proteolysis yielding protective antimicrobial peptides. J Proteome Res 12: 2295–2304
57. Govender P, Dunn MJ, Donnelly SC (2009) Proteomics and the lung: analysis of bronchoalveolar lavage fluid. Proteomics Clin Appl 3:1044–1051
58. Foster MW, Thompson JW, Que LG et al (2013) Proteomic analysis of human bronchoalveolar lavage fluid after subsgemental exposure. J Proteome Res 12:2194–2205
59. Lee AS (2004) American Thoracic Society. Bronchoalveolar Lavage. Available from http://www.thoracic.org/clinical/critical-care/criticalcare-procedures/bronchoalveolar-lavage.php
60. Pastor MD, Nogal A, Molina-Pinelo S et al (2013) Identification of proteomic signatures associated with lung cancer and COPD. J Proteomics 89:227–237
61. Kosanam H, Sato M, Batruch I et al (2012) Differential proteomic analysis of bronchoalveolar lavage fluid from lung transplant patients with and without chronic graft dysfunction. Clin Biochem 45:223–230
62. Cederfur C, Malmstrom J, Nihlberg K et al (2012) Glycoproteomic identification of galectin- 3 and -8 ligands in bronchoalveolar lavage of mild asthmatics and healthy subjects. Biochim Biophys Acta 1820:1429–1436
63. Ruhlen RL, Sauter ER (2007) Proteomics of nipple aspirate fluid, breast cyst fluid, milk, and colostrum. Proteomics Clin Appl 1:845–852
64. Ruhlen RL, Sauter ER (2007) Proteomic analysis of breast tissue and nipple aspirate fluid for breast cancer detection. Biomark Med 1:251–260
65. Pavlou MP, Kulasingam V, Sauter ER et al (2010) Nipple aspirate fluid proteome of healthy females and patients with breast cancer. Clin Chem 56:848–855
66. Pawlik TM, Hawke DH, Liu Y et al (2006) Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 6:68
67. Alexander H, Stegner AL, Wagner-Mann C et al (2004) Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res 10:7500–7510
68. Noble J, Dua RS, Locke I et al (2007) Proteomic analysis of nipple aspirate fluid throughout the menstrual cycle in healthy premenopausal women. Breast Cancer Res Treat 104:191–196
69. Cho CK, Smith CR, Diamandis EP (2010) Amniotic fluid proteome analysis from Down syndrome pregnancies for biomarker discovery. J Proteome Res 9:3574–3582
70. Kolialexi A, Tounta G, Mavrou A et al (2011) Proteomic analysis of amniotic fluid for the diagnosis of fetal aneuploidies. Expert Rev Proteomics 8:175–185
71. Amniocentesis protocol (2011) Available from http://hsc.unm.edu/som/obgyn/docs/protocols/20.pdf
72. Tsangaris GT, Kolialexi A, Karamessinis PM et al (2006) The normal human amniotic fluid supernatant proteome. In Vivo 20:479–490
73. Cho CK, Shan SJ, Winsor EJ et al (2007) Proteomics analysis of human amniotic fluid. Mol Cell Proteomics 6:1406–1415
74. Barbhuiya MA, Sahasrabuddhe NA, Pinto SM et al (2011) Comprehensive proteomic analysis of human bile. Proteomics 11:4443–4453
75. Farina A, Dumonceau JM, Lescuyer P (2009) Proteomic analysis of human bile and potential applications for cancer diagnosis. Expert Rev Proteomics 6:285–301
76. Farina A, Dumonceau JM, Frossard JL et al (2009) Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer. J Proteome Res 8:159–169
77. Tang LJ, De Seta F, Odreman F et al (2007) Proteomic analysis of human cervical-vaginal fluids. J Proteome Res 6:2874–2883
78. Shaw JL, Smith CR, Diamandis EP (2007) Proteomic analysis of human cervico-vaginal fluid. J Proteome Res 6:2859–2865
79. Lockwood CJ, Senyei AE, Dische MR et al (1991) Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 325:669–674
80. Kalinka J, Sobala W, Wasiela M et al (2005) Decreased proinflammatory cytokines in cervicovaginal fluid, as measured in midgestation, are associated with preterm delivery. Am J Reprod Immunol 54:70–76
81. Dasari S, Pereira L, Reddy AP et al (2007) Comprehensive proteomic analysis of human cervical-vaginal fluid. J Proteome Res 6: 1258–1268
82. Di Quinzio MK, Oliva K, Holdsworth SJ et al (2007) Proteomic analysis and characterisation of human cervico-vaginal fluid proteins. Aust N Z J Obstet Gynaecol 47:9–15
83. Pereira L, Reddy AP, Jacob T et al (2007) Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res 6:1269–1276
84. Davalieva K, Kiprijanovska S, Noveski P et al (2012) Human seminal plasma proteome study: a search for male infertility biomarkers. Balkan J Med Genet 15:35–38
85. Milardi D, Grande G, Vincenzoni F et al (2012) Proteomic approach in the identification of fertility pattern in seminal plasma of fertile men. Fertil Steril 97:67–73 e61
86. Davalieva K, Kiprijanovska S, Noveski P et al (2012) Proteomic analysis of seminal plasma in men with different spermatogenic impairment. Andrologia 44:256–264
87. Hassan MI, Kumar V, Kashav T et al (2007) Proteomic approach for purification of seminal plasma proteins involved in tumor proliferation. J Sep Sci 30:1979–1988
88. WHO (2010) Laboratory manual for the examination and processing of human semen, 5th edn. WHO, Geneva
89. da Silva BF, Souza GH, lo Turco EG et al (2013) Differential seminal plasma proteome according to semen retrieval in men with spinal cord injury. Fertil Steril 100: 959–969